Authors:
CURE H
KRAKOWSKI I
ADENIS A
TUBIANA N
KERBRAT P
ROCHE H
CHEVALLIER B
LENTZ MA
FUMOLEAU P
CHOLLET P
Citation: H. Cure et al., RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/, European journal of cancer, 34(3), 1998, pp. 422-423
Authors:
KRAKOWSKI I
MONIN S
DAHAN R
CHEVALIER H
KHAYAT D
SCHRAUB S
SERIN D
Citation: I. Krakowski et al., IMPACT OF REPEATED INVASIVE PROCEDURES IN ONCOLOGY - CONFRONTATION OFPHYSICIAN, NURSE AND PATIENT OPINIONS, Annals of oncology, 9, 1998, pp. 100-100
Authors:
TOURANI JM
PFISTER C
BERDAH JF
BENHAMMOUDA A
SALZE P
MONNIER A
PAULE B
GUILLET P
CHRETIEN Y
BREWER Y
DIPALMA M
UNTEREINER M
MALAURIE E
TADRIST Z
PAVLOVITCH JM
HAUTEVILLE D
MEJEAN A
AZAGURY M
MAYEUR D
LUCAS V
KRAKOWSKI I
LARREGAINFOURNIER D
ABOURACHID H
ANDRIEU JM
CHASTANG C
Citation: Jm. Tourani et al., OUTPATIENT TREATMENT WITH SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA ADMINISTRATION IN COMBINATION WITH FLUOROURACIL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A SEQUENTIAL NONRANDOMIZED-PHASE-II STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2505-2513
Authors:
DEGARDIN M
CAPPELAERE P
KRAKOWSKI I
FARGEOT P
CUPISSOL D
BRIENZA S
Citation: M. Degardin et al., PHASE-II TRIAL OF OXALIPLATIN (L-OHP) IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, European journal of cancer. Part B, Oral oncology, 32B(4), 1996, pp. 278-279
Authors:
CAPPELAERE P
FOURNIER C
ROLLAND F
MEEUS L
DOMENGE C
KRAKOWSKI I
DEGISLAIN C
CHAUVERGNE J
DUFOURESQUERRE F
PION JM
HECQUET B
Citation: P. Cappelaere et al., PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/, Bulletin du cancer, 83(7), 1996, pp. 559-565
Authors:
KRAKOWSKI I
GESTIN Y
JAULMES F
LAKDJA F
MEYNADIER J
POULAIN P
DIBORGO CP
REBATTU P
SCHACH R
GOLDBERG J
BOUREAU F
FALCOFF H
GUILLAIN H
LARUE F
MAGNET M
SALAMAGNE M
SERRIE A
TRECHOT P
VERDIE JC
Citation: I. Krakowski et al., RECOMMENDATIONS FOR GOOD PRACTICE IN THE MANAGEMENT OF CANCER PAIN INTHE ADULT AND THE CHILD, Bulletin du cancer, 83, 1996, pp. 9-81
Authors:
DIERAS V
CHEVALLIER B
KERBRAT P
KRAKOWSKI I
ROCHE H
MISSET JL
LENTZ MA
AZLI N
MURAWSKY M
RIVA A
POUILLART P
FUMOLEAU P
Citation: V. Dieras et al., A MULTICENTER PHASE-II STUDY OF DOCETAXEL 75 MG M(-2) AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, British Journal of Cancer, 74(4), 1996, pp. 650-656
Authors:
CHEVALLIER B
FUMOLEAU P
KERBRAT P
DIERAS V
ROCHE H
KRAKOWSKI I
AZLI N
BAYSSAS M
LENTZ MA
VANGLABBEKE M
Citation: B. Chevallier et al., DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, Journal of clinical oncology, 13(2), 1995, pp. 314-322
Authors:
BUI BN
CHEVALLIER B
CHEVREAU C
KRAKOWSKI I
PENY AM
THYSS A
MAUGARDLOUBOUTIN C
CUPISSOL D
FARGEOT P
BONICHON F
COINDRE JM
GIL B
COURCHABERNAUD V
Citation: Bn. Bui et al., EFFICACY OF LENOGRASTIM ON HEMATOLOGIC TOLERANCE TO MAID CHEMOTHERAPYIN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA AND CONSEQUENCES ON TREATMENT DOSE-INTENSITY, Journal of clinical oncology, 13(10), 1995, pp. 2629-2636
Authors:
CAPPELAERE P
HECQUET B
ROLLAND F
MEEUS L
DOMENGE C
KRAKOWSKI I
DEGISLAIN C
CHAUVERGNE J
DUFOURESQUERRE F
CARDE P
Citation: P. Cappelaere et al., RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE, Bulletin du cancer, 82(9), 1995, pp. 732-737
Authors:
KRAKOWSKI I
FALCOFF H
GESTIN Y
GOLDBERG J
GUILLAIN H
JAULMES F
LAKDJA F
LARUE F
MAGNET M
MEYNADIER J
POULAIN P
DIBORGO CP
REBATTU P
SALAMAGNE M
SERRIE A
SCHACH R
TRECHOT P
VERDIE JC
Citation: I. Krakowski et al., GUIDELINES FOR MANAGEMENT OF CANCER PAIN IN CHILDREN AND ADULTS, Bulletin du cancer, 82, 1995, pp. 245-315
Authors:
RIVIERE A
BECKENDORF V
BONNETERRE J
BUI NB
CATIMEL G
CUPISSOL D
FARGEOT P
HECQUET B
KRAKOWSKI I
MADELAINECHAMBRIN I
MIHURA J
ROCHE H
RUFFIE P
SCHNEIDER M
PHILIP T
Citation: A. Riviere et al., STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY, Bulletin du cancer, 82, 1995, pp. 453-485
Authors:
KERBRAT P
ADENIS A
REBATTU P
ROCHE H
CHEVALLIER B
CHOLLET P
KRAKOWSKI I
LENTZ MA
FUMOLEAU P
Citation: P. Kerbrat et al., PHASE-II STUDY OF CYSTEMUSTINE IN METASTATIC COLORECTAL-CARCINOMA - ATRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 29A(11), 1993, pp. 1597-1599
Authors:
CONROY T
GEOFFROIS L
GUILLEMIN F
LUPORSI E
KRAKOWSKI I
SPAETH D
FRASIE V
VOLFF D
Citation: T. Conroy et al., SIMPLIFIED CHRONOMODULATED CONTINUOUS-INFUSION OF FLOXURIDINE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Cancer, 72(7), 1993, pp. 2190-2197
Authors:
SPAETH D
CONROY T
KRAKOWSKI I
GEOFFROIS L
LUPORSI E
RIOS M
WEBER B
Citation: D. Spaeth et al., CISPLATINUM AND LONG-TERM CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED BREAST-CANCER - A RETROSPECTIVE STUDY OF 77 PATIENTS, Bulletin du cancer, 80(4), 1993, pp. 351-356